Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Price:
3.25
USD
2.52%
Market Closed
Market Cap:
$129.4m
Balance Sheet
Balance Sheet Decomposition
Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc
Balance Sheet
Oramed Pharmaceuticals Inc
Oramed Pharmaceuticals Inc
Currency: USD
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
28
|
41
|
9
|
54
|
|
| Cash Equivalents |
28
|
41
|
9
|
54
|
|
| Short-Term Investments |
119
|
115
|
153
|
88
|
|
| Other Current Assets |
2
|
1
|
1
|
1
|
|
| Total Current Assets |
148
|
157
|
163
|
143
|
|
| PP&E Net |
1
|
2
|
2
|
1
|
|
| Long-Term Investments |
29
|
3
|
56
|
11
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
|
| Total Assets |
178
N/A
|
162
-9%
|
221
+36%
|
155
-30%
|
|
| Liabilities | |||||
| Accounts Payable |
5
|
2
|
1
|
1
|
|
| Accrued Liabilities |
0
|
2
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
51
|
0
|
|
| Other Current Liabilities |
3
|
1
|
0
|
4
|
|
| Total Current Liabilities |
7
|
6
|
53
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
1
|
1
|
1
|
|
| Other Liabilities |
4
|
5
|
4
|
4
|
|
| Total Liabilities |
11
N/A
|
10
-14%
|
57
+479%
|
9
-84%
|
|
| Equity | |||||
| Common Stock |
1
|
1
|
0
|
0
|
|
| Retained Earnings |
127
|
163
|
158
|
177
|
|
| Additional Paid In Capital |
293
|
314
|
321
|
322
|
|
| Total Equity |
167
N/A
|
152
-9%
|
164
+8%
|
146
-11%
|
|
| Total Liabilities & Equity |
178
N/A
|
162
-9%
|
221
+36%
|
155
-30%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
38
|
40
|
40
|
40
|
|
Switch to:
Switch to:
See Also
Discover More
